Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Vos

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of RalDavid J J de Gorter, Johanna C M Vos, Steven T Pals, et al.
Experimental Neurology|June 2, 2000
Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal culturesC M Vos, L Sjulson, A Nath, et al.
Journal of Neuroimmunology|September 21, 2000
Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegenerationC M Vos, S Gartner, R M Ransohoff, et al.
AIDS (London, England)|March 10, 2001
Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrierI C van der Sandt, C M Vos, L Nabulsi, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2008
Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysisIngrid M Overes, T Henriëtte Levenga, Johanna C M Vos, et al.
Targeted Oncology|December 23, 2014
Sunitinib does not attenuate contractile force following a period of ischemia in isolated human cardiac muscleAnna M J Thijs, Saloua El Messaoudi, Johanna C M Vos, et al.
Blood|December 17, 2008
Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cellsWieger J Norde, Ingrid M Overes, Frans Maas, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of RalDavid J J de Gorter, Johanna C M Vos, Steven T Pals, et al.
Experimental Neurology|June 2, 2000
Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal culturesC M Vos, L Sjulson, A Nath, et al.
Journal of Neuroimmunology|September 21, 2000
Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegenerationC M Vos, S Gartner, R M Ransohoff, et al.
AIDS (London, England)|March 10, 2001
Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrierI C van der Sandt, C M Vos, L Nabulsi, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2008
Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysisIngrid M Overes, T Henriëtte Levenga, Johanna C M Vos, et al.
Targeted Oncology|December 23, 2014
Sunitinib does not attenuate contractile force following a period of ischemia in isolated human cardiac muscleAnna M J Thijs, Saloua El Messaoudi, Johanna C M Vos, et al.
Blood|December 17, 2008
Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cellsWieger J Norde, Ingrid M Overes, Frans Maas, et al.
Pageof 2